Judy W Griffin
University of Tennessee Health Science Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Judy W Griffin.
American Journal of Sports Medicine | 1987
T. David Sisk; Susan W Stralka; Mary B. Deering; Judy W Griffin
The effect of prolonged daily electrical stimulation (ES) on quadriceps strength in 22 patients during the 6 weeks following anterior cruciate reconstruction was investigated. Patients were randomly assigned to re ceive either a combination of ES and exercise or exer cise alone. Isometric quadriceps strength was meas ured at the 7th, 8th, and 9th postoperative weeks. No significant difference in strength existed between the groups as a result of ES. A significant difference in strength did exist between competitive and recreational athletes regardless of treatment. Further research is needed to determine if the addition of ES to isometric exercise during immobilization can significantly retard strength loss after anterior cruciate reconstructive sur gery.
Orthopedics | 1987
Robert E Tooms; Judy W Griffin; Sheila Green; Kistan Cagle
The purpose of this study was to assess the effect of viscoelastic shoe inserts on pain in nursing students. Students (N = 100) were randomly assigned to control and viscoelastic groups. The viscoelastic group used viscoelastic insoles in their work shoes for five weeks. A pain questionnaire was used to measure location and intensity of post-work pain. The questionnaire was administered as a pre-test and after five weeks. Post-test comparisons between groups indicated significant differences which were not present at pre-test. The viscoelastic group reported a significant peripheral shift in pain location from back to lower extremity; the viscoelastic group also showed significant changes in duration of post-work pain and frequency of pain during the workday. The clinical efficacy of viscoelastic shoe inserts for modifying weight bearing-induced back pain is supported. Further clinical research into the therapeutic and prophylactic value of shock-attenuating shoe inserts for healthy as well as patient populations is advocated.
Neuromuscular Disorders | 1994
Judy W Griffin; Robert E Tooms; Roger Vander Zwaag; Mary L. O'Toole; Tulio E. Bertorini
This study investigated the potential value of eccentric (ECC) and concentric (CONC) isokinetic testing for quantifying motor deficit in patients with spastic paresis secondary to motor neuron disease. We hypothesized that, at a moderately fast (120 degrees s-1) angular velocity, spastic patients would demonstrate different ECC-CONC torque relationships from healthy controls or patients with non-spastic neuromuscular disorders. Eleven patients with motor neuron disease having clinical evidence of spasticity, and 11 disease-control patients (with non-spastic disorders, e.g. lower motor neuron disease or myopathy) underwent isokinetic testing. One healthy subject was matched to each of the 22 patients. The average torque generated during maximal voluntary ECC and CONC knee flexion (KF) and extension (KE) was measured using an isokinetic dynamometer (Kin-Com). Reliability was established (all ICC > or = 0.97) for patient torque measurements. Relative strength (% of control subject torque) in spastic patients was significantly higher for ECC than for CONC actions in both KF and KE; conversely, in non-spastic disease-control patients relative strength was not affected by the type of muscle action. The ECC/CONC average torque ratios for KE and KF at 120 degrees s-1 were significantly greater in spastic patients than controls, but did not differ from controls in non-spastic patients. In spastic patients the ECC-CONC imbalances were related to ambulatory dysfunction. In four spastic patients followed with serial testing, the disproportion between ECC and CONC voluntary capacity persisted over time.(ABSTRACT TRUNCATED AT 250 WORDS)
Cranio-the Journal of Craniomandibular Practice | 2001
Eddy Zeno; Judy W Griffin; Charles H. Boyd; Akinniran Oladehin; Rick Kasser
ABSTRACT There are few reports analyzing the effects of exercise on patients with temporomandibular disorders. This paper presents a case study examining whether there were additional benefits from performing neuromuscular control home exercises (NMCHE) in a patient with temporomandibular disorder who was already receiving conventional treatment. A woman, 41 years of age, completed a health status questionnaire called the TMJ Scale prior to being accepted. She completed additional TMJ Scales after receiving conventional treatment and again after conventional treatment was combined with neuromuscular control home exercises. Based on the TMJ Scales best subscore indicator of the presence or absence of a temporomandibular disorder, the patient did not derive benefit from conventional treatment without exercise. However, she received a large benefit from the addition of NMCHE. It was concluded that exercises for patients with temporomandibular disorders may be beneficial to those who do not improve with conventional treatment alone.
The American Journal of the Medical Sciences | 1995
David F. Nutting; Elizabeth A. Schriock; Genaro M. A. Palmieri; Joyce B. Bittle; Martha C. Edwards; Harold S. Sacks; B. Jean Elmendorf; Linda H. Horner; Tulio E. Bertorini; Judy W Griffin
ABSTRACT: Although receptors for somatostatin are found in bone cells, the effect of somatostatin analogs on calcium metabolism is unknown. The authors studied, in a metabolic ward, the effect of octreotide (a long‐acting somatostatin analog) and a placebo in two 6‐day calcium balance periods in 8 children with Duchenne muscular dystrophy. As expected, octreotide (2 &mgr;g/kg, subcutaneously, every 8 hours) reduced serum growth hormone and somatomedin (IGF‐1) to levels found in growth hormone deflciency. Octreotide enhanced calcium retention by 30% (96 mg daily [P < 0.04]) in 7 boys for whom complete data (diet, urine, and fecal calcium) were available. In 6 children with urinary calcium excretion (UCa) greater than 50 mg daily, octreotide markedly lowered UCa, from 114 ± 23 mg daily to 61 ± 9 mg daily (P < 0.03). Calcium retention occurred in patients with or without initial hypercalciuria, but the higher the basal UCa, the greater was the inhibition by octreotide (r = 0.79; P < 0.03). Inactive, nonambulatory patients had a more pronounced response of UCa to octreotide (P < 0.02). Octreotide caused a mild, nonsignificant reduction in fecal calcium, with no major changes in serum calcium, phosphorus, parathyroid hormone, urinary excretion of sodium and potassium, or in creatinine clearance. Based on the current observations and the presence of receptors for somatostatin in bone cells, this hormone may have, at least on a short‐term basis, an anabolic effect on calcium, perhaps favoring its deposition in bone.
Physical Therapy | 1991
Judy W Griffin; Robert E Tooms; Ruth A Mendius; Judy K Clifft; Roger Vander Zwaag; Faten El-Zeky
Physical Therapy | 1986
Judy W Griffin
Physical Therapy | 1987
Judy W Griffin
Physical Therapy | 1993
Judy W Griffin; Elizabeth A Tolley; Robert E Tooms; Ruth A Reyes; Judy K. Clifft
Muscle & Nerve | 1996
Genaro M. A. Palmieri; Tulio E. Bertorini; Judy W Griffin; Masanori Igarashi; James G. Karas